Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 8, December

Can we Target the Chemokine Network for Cancer Therapeutics?

Volume:6   Issue: 8
Pp: 659-670
Ryan Giles and Robert D. Loberg
DOI: 10.2174/156800906779010245
Published on: 01 March, 2012

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

Volume:6   Issue: 8
Pp: 671-679
A. Ferrajoli, S. Faderl, F. Ravandi and Z. Estrov
DOI: 10.2174/156800906779010227
Published on: 01 March, 2012

Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids

Volume:6   Issue: 8
Pp: 681-689
Nam Deuk Kim, Eunok Im, Young Hyun Yoo and Yung Hyun Choi
DOI: 10.2174/156800906779010236
Published on: 01 March, 2012

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

Volume:6   Issue: 8
Pp: 691-710
Igor Astsaturov, Roger B. Cohen and Paul M. Harari
DOI: 10.2174/156800906779010191
Published on: 01 March, 2012

Chemopreventive Agents Alters Global Gene Expression Pattern: Predicting their Mode of Action and Targets

Volume:6   Issue: 8
Pp: 711-727
Bhagavathi A. Narayanan
DOI: 10.2174/156800906779010218
Published on: 01 March, 2012

Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes

Volume:6   Issue: 8
Pp: 729-751
Laurent Dolle, Herman T. Depypere and Marc E. Bracke
DOI: 10.2174/156800906779010263
Published on: 01 March, 2012

ERRATUM

Volume:6   Issue: 8
Pp: 753-753

DOI: 10.2174/156800906779010254
Published on: 01 March, 2012